Our latest articles

Vantage logo

Pfizer rescues biotech

The $43bn deal for Seagen marks the biggest biopharma acquisition since the pre-crash takeouts of Allergan and Celgene.

Vantage logo

Flotations versus blank cheques

Neither route to the stock market covered itself in glory in the recent bull market. But how do returns really stack up?